Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma
Abstract Coronavirus disease 2019 (COVID-19), an extremely contagious illness, has posed enormous challenges to healthcare systems around the world. Although the evidence on COVID-19 management is growing, antiviral medication is still the first line of treatment. Therefore, it is critical that effe...
Saved in:
Main Authors: | Amal B. Ahmed, Maha M. Abdelrahman, Fadwa H. Edrees |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13065-024-01364-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral and anti-inflammatory activities of favipiravir and quinine sulfate against dengue virus serotype 1 in vitro
by: Regita Aulia Rosalina, et al.
Published: (2025-03-01) -
Validation of Colchicine Assay Method for Therapeutic Drug Monitoring in Human Plasma
by: Fadime Canbolat
Published: (2022-12-01) -
Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)
by: Taweegrit Siripongboonsitti, et al.
Published: (2024-12-01) -
Assessment of the impact of different SARS-CoV-2 inactivation operations on colistin sulfate plasma concentration results
by: Ying-Chao Ma, et al.
Published: (2025-01-01) -
The Impact of Coronavirus Disease-19 on Pregnancy Outcomes, A Case Series
by: Bilge Cetinkaya Demir, et al.
Published: (2023-03-01)